focus -WSS

focus

author：fashion 2025-09-30 00:34:28 - browse：78433

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack [that] kicked off a cascading series of crises that are unmasking some deep vulnerabilities in the core of our health care system”: the February Change Healthcare cyberattack that is still disrupting payment processing across the country.

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth. At one point, Sen. Thom Tillis (R-N.C.) held up a fifth-edition copy of “Hacking for Dummies” during the hearing.

“This is some basic stuff that was missed,” he said, referring to the fact that the hackers gained access to a Change server that didn’t have multi-factor authentication, a big problem for a company whose business is digital data. “So shame on internal audit, external audit and your system folks, those tasked with redundancy, they’re not doing their job. And as a result, we have a data breach.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Air quality improving but still lags in Black, Hispanic communities

WSS

AstraZeneca stays mum on Medicare drug pricing negotiations

Readout LOUD: Venture capital, Gilead, and more M&A

Amylyx ALS drug failure raises questions and concerns

Johnson & Johnson sued for allegedly overpaying for workers' drugs

A single Democrat is willing to weaken Medicare negotiation power

Medicare Advantage plans can’t deny care with AI, CMS warns

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

knowledge

How to save PrEP access — and even expand it

Texas Medical Board asked to define abortion emergency exception

After affirmative action ruling, medical educators look to 'holistic review'

The problem with charging patients to message their doctors

New air purifier tech could be key to improving indoor air quality

Top private equity targets in 2023: cardiology, clinical trials, lasers

23andMe had bad news about my health. I wish a person had delivered it

The Biogen Aduhelm mess could happen again

Novavax promises a turnaround & Lilly roils the obesity market

Problems with a popular proposal to regulate AI in health care

hotspot

Texas Medical Board asked to define abortion emergency exception

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Cano Health’s bankruptcy is a warning for Medicare Advantage

In his State of the Union, Biden takes clear aim at 'Big Pharma'

What’s missing from the debate over nursing home staff minimums

Change Healthcare cyberattack prompts Medicare loan program

leisure time

focus

hotspot

explore